Trevi Therapeutics
TRVI
TRVI
37 hedge funds and large institutions have $83.3M invested in Trevi Therapeutics in 2022 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
23% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 13
91% less call options, than puts
Call options by funds: $2K | Put options by funds: $22K
Holders
37
Holding in Top 10
–
Calls
$2K
Puts
$22K
Top Buyers
| 1 | +$2.43M | |
| 2 | +$936K | |
| 3 | +$294K | |
| 4 |
Millennium Management
New York
|
+$227K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$222K |
Top Sellers
| 1 | -$2.4M | |
| 2 | -$1.64M | |
| 3 | -$1.33M | |
| 4 |
Morgan Stanley
New York
|
-$827K |
| 5 |
MCM
MAI Capital Management
Independence,
Ohio
|
-$576K |